Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux

2 May 2019

Abstract excerpt

Pancreatic cancer is one of the most lethal types of tumors with no effective therapy available; is currently the third leading cause of cancer in developed countries; and is predicted to become the second deadliest cancer in the United States by 2030. Due to the marginal benefits of current standard chemotherapy, the identification of new therapeutic targets is greatly required. Considering that cAMP pathway is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Epigenetics and DNA Methylation
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31043460
DOI: 10.1124/mol.118.115444

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP EffluxPMID 31043460Read ↗

Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressivenessSemantic proximity Read ↗

The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cellsSemantic proximity Read ↗

ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?Semantic proximity Read ↗

Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugsSemantic proximity Read ↗

The Role of Epac in Cancer ProgressionSemantic proximity Read ↗

Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistanceSemantic proximity Read ↗

TRPM2 promotes the proliferation and invasion of pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels.Semantic proximity Read ↗

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancerSemantic proximity Read ↗

Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21Semantic proximity Read ↗

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancerSemantic proximity Read ↗

Blockades Adenosine Receptor 2B Suppresses Pancreatic Adenocarcinoma Progression by Inhibiting Leukemia Inhibitory Factor Secretion from MacrophagesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.